

Fundamental dimension Equity attribute | APGPeer $39.45▲+1.68% Cap $17.05BP/E -58.9x QuantScore47/100 | ABMLeader $53.67▼-0.39% Cap $3.15BP/E 19.3x QuantScore53/100 | AMRCPeer $18.53▼-2.88% Cap $983.3MP/E 35.0x QuantScore37/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
35/100 |
73/100 |
26/100 |
Valuation Multiples, PEG & DCF upside | 46/100 | 95/100 | 47/100 |
Health Piotroski, Altman Z, leverage & liquidity | 40/100 | 40/100 | 22/100 |
Growth Revenue / earnings growth & margins | 35/100 | 30/100 | 15/100 |
Sentiment Analyst ratings, targets & revisions | 78/100 | 28/100 | 75/100 |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | -58.9x | 19.3x | 35.0x |
Forward P/E (next FY) | 22.7x | 13.4x | 14.8x |
EV / EBITDA (TTM) | 22.3x | 11.2x | 11.5x |
Price / Sales | 2.0x | 0.3x | 0.5x |
Price / Free Cash Flow | 25.2x | 10.1x | -1.9x |
PEG ratio | 0.17 | 0.38 | -0.63 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 6 / 9 | 7 / 9 | 4 / 9 |
Altman Z-Score | 2.84 (Grey) | 2.81 (Grey) | 1.06 (Distress) |
Total debt / equity | 1.09 | 1.05 | 1.50 |
Quick ratio | 1.3x | 1.4x | 1.7x |
Interest coverage | 6.5x | 3.2x | 1.4x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | +12.7% | +4.6% | +9.2% |
Net income growth YoY | +20.8% | +99.5% | -22.0% |
Gross margin (TTM) | 29.3% | 11.7% | 16.1% |
Operating margin (FY) | 7.0% | 3.7% | 6.7% |
FCF margin (FY) | 8.4% | 1.8% | -22.6% |
5. Trailing price performancePrice change over period |
1M return | +4.3% | +8.3% | -14.5% |
3M return | -0.3% | +12.5% | -14.8% |
6M return | -18.8% | +33.6% | -33.6% |
Year to date | +3.1% | +26.9% | -36.7% |
1Y return | +13.5% | +17.5% | -56.4% |
3Y return | +133.8% | +34.0% | -37.7% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $11.59 -70.6% premium | $71.80 +33.8% upside | $-220.25 -1288.6% premium |
Wall Street consensus target | $52.20 +32.3% · range $47.00–$55.00 | $51.88 -3.3% · range $49.00–$54.00 | $44.67 +141.1% · range $36.00–$62.00 |
Consensus stance | 100% Buy0% Hold0% Sell | 42% Buy58% Hold-0% Sell | 75% Buy25% Hold0% Sell |